Welcome

EAACI Congress 2023 Back

09 - 11 June 2023 Hamburg, Germany

Artem Zharkov

Switzerland

Artem Zharkov

Employee of Novartis

Sessions

Saturday 10 Jun

16:45 - 16:57 Long-term treatment with remibrutinib shows favourable safety profile and sustained efficacy in patients with chronic spontaneous urticaria: Final results from a 52-week phase 2b extension study ORAL Session Hall Y 03+04